Go here to see the original:
Seer to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

Read more from the original source:
Palisade Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference and Biotech Showcase

Go here to see the original:
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

See more here:
Mindset Pharma Recaps 2021 Milestones and Highlights

Read more from the original source:
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital

Excerpt from:
Notification about final share buy-back

More here:
Immunovant Provides Regulatory Update Regarding Initiation of Phase 3 Trial for Batoclimab in Myasthenia Gravis in the First Half of 2022

View original post here:
Gritstone Announces Presentations during Three Upcoming Investor Conferences

Read more here:
Registration Now Open For Tribe Public’s Webinar Event "Addressing The Increasing Demand For Rare Cannabinoids" Featuring InMed’s...

Link:
Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference

Go here to read the rest:
Lotus Ventures Inc. Reports Fiscal 2021 Results

See original here:
BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update

Read the original:
Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant exercises

Read more here:
Madrigal Provides Update on Timeline for Topline Results from the Phase 3 MAESTRO-NAFLD-1 Clinical Trial of Resmetirom

See the original post:
Total number of shares and voting rights in Zealand Pharma at December 30, 2021

Follow this link:
Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From COVAXIN™ (BBV152), COVID-19 Candidate Vaccine, in Children 2...

Follow this link:
Akari Therapeutics, Plc Announces $6.0 Million Registered Direct Offering

The rest is here:
Mesoblast Provides Update Following Meeting With FDA’s OTAT on Remestemcel-L for Children With Acute Graft Versus Host Disease

Read more from the original source:
Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes

Visit link:
MedMira Reports First Quarter Results FY2022